Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
Ondansetron
Medication labelOndansetron orally disintegrating tablets are indicated for the prevention of nausea and vomiting associated with: highly emetogenic cancer…
Why this: Advisory · dailymed-prescription
Ondansetron orally disintegrating tablets are indicated for the prevention of nausea and vomiting associated with: highly emetogenic cancer chemotherapy, including cisplatin greater than or equal to 50 mg/m 2 initial and repeat courses of moderately emetogenic cancer chemotherapy radiotherapy in patients receiving either total body irradiation, single high-dose fraction to the abdomen, or daily fractions to the abdomen Ondansetron orally disintegrating tablets also indicated for the prevention of postoperative nausea and/or vomiting.
- generic_name
- ondansetron
- product_names
- Ondansetron
- ndc
- 67296-1137, 57237-077, 67296-1137-1, 67296-1137-2, 67296-1137-3
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en